Travere Therapeutics to Participate at Upcoming Investor Conferences Aug 5, 2025 04:30PM
Travere Therapeutics (TVTX) PT Raised to $47 at Canaccord Genuity Apr 10, 2025 06:28AM
Travere Therapeutics (TVTX) PT Raised to $45 at Canaccord Genuity Feb 12, 2025 06:36AM
Travere Therapeutics (TVTX) PT Lowered to $22 at Canaccord Genuity Sep 30, 2024 06:59AM
Travere Therapeutics (TVTX) PT Raised to $23 at Canaccord Genuity Sep 10, 2024 07:23AM


Aug 6, 2024 04:30PM Travere Therapeutics to Present at Upcoming Investor Conferences
May 7, 2024 06:20AM Travere Therapeutics (TVTX) PT Raised to $18 at Canaccord Genuity
Jul 14, 2022 07:51AM UPDATE: Canaccord Genuity Assumes Travere Therapeutics (TVTX) at Buy
Dec 17, 2021 07:30AM Travere Therapeutics (TVTX) PT Raised to $49 at Canaccord Genuity
Sep 17, 2021 07:18AM Travere Therapeutics (TVTX) PT Lowered to $42 at Canaccord Genuity
Feb 17, 2021 04:05PM Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Feb 17, 2021 04:05PM Travere Therapeutics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Feb 12, 2021 06:05AM Travere Therapeutics (TVTX) Prices 6.55M Share Common Offering at $26.75/Sh
Feb 11, 2021 10:03PM Travere Therapeutics Announces Pricing of Public Offering of Common Stock
Feb 11, 2021 10:03PM Travere Therapeutics Announces Pricing of Public Offering of Common Stock